FDA Innovation And Integrity Will Be Goodman's Role Under Reorganization

FDA's Office of Chief Scientist will lose some specific responsibilities but gain a broader mission under a reorganization proposed by Commissioner Margaret Hamburg

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet